In conclusion, we clarified that MRTO4 is an independent biomarker for prognosis and associated with clinical stage, tumor grade, immune cell infiltration, IPS, TME score, TMB, drug sensitivity, and immune checkpoint gene expression, and we explored the biological functions and signaling pathways of MRTO4 in HCC. Here, MRTO4 is linked to hepatocellular carcinoma.